Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$29.53
+6.5%
$29.32
$13.74
▼
$63.63
$6.47B2.4410.42 million shs16.28 million shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$39.22
+2.9%
$42.87
$35.12
▼
$64.16
$170.21B0.7615.29 million shs14.77 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$29.47
+0.9%
$27.94
$23.62
▼
$29.88
$166.49B0.3232.73 million shs32.87 million shs
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$5.94
+2.3%
$6.24
$4.40
▼
$9.89
$1.06B2.143.72 million shs2.93 million shs
WW International, Inc. stock logo
WW
WW International
$14.63
+2.5%
$15.58
$8.36
▼
$38.38
$146.29M1.73281,835 shs152,817 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
+6.44%+5.28%+5.94%-10.21%-52.96%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
+2.84%+2.70%-7.55%-22.01%-30.84%
Pfizer Inc. stock logo
PFE
Pfizer
+0.85%+5.90%+7.05%+17.48%+20.79%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
+2.57%+7.68%-9.56%-36.93%-33.39%
WW International, Inc. stock logo
WW
WW International
+2.52%-2.21%-3.30%+0.41%-49.79%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$29.53
+6.5%
$29.32
$13.74
▼
$63.63
$6.47B2.4410.42 million shs16.28 million shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$39.22
+2.9%
$42.87
$35.12
▼
$64.16
$170.21B0.7615.29 million shs14.77 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$29.47
+0.9%
$27.94
$23.62
▼
$29.88
$166.49B0.3232.73 million shs32.87 million shs
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$5.94
+2.3%
$6.24
$4.40
▼
$9.89
$1.06B2.143.72 million shs2.93 million shs
WW International, Inc. stock logo
WW
WW International
$14.63
+2.5%
$15.58
$8.36
▼
$38.38
$146.29M1.73281,835 shs152,817 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
+6.44%+5.28%+5.94%-10.21%-52.96%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
+2.84%+2.70%-7.55%-22.01%-30.84%
Pfizer Inc. stock logo
PFE
Pfizer
+0.85%+5.90%+7.05%+17.48%+20.79%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
+2.57%+7.68%-9.56%-36.93%-33.39%
WW International, Inc. stock logo
WW
WW International
+2.52%-2.21%-3.30%+0.41%-49.79%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2.13
Hold$32.439.82% Upside
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
2.00
Hold$59.4451.54% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.14
Hold$28.72-2.52% Downside
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
2.25
Hold$7.5426.78% Upside
WW International, Inc. stock logo
WW
WW International
2.00
Hold$25.0070.88% Upside

Current Analyst Ratings Breakdown

Latest NVO, PFE, TDOC, HIMS, and WW Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/13/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingBuy
10/12/2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Set Price TargetMarket Perform$47.00 ➝ $40.00
10/9/2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Reiterated RatingNeutral
10/9/2026
Pfizer Inc. stock logo
PFE
Pfizer
Boost Price TargetNeutral$28.00 ➝ $30.00
10/8/2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
DowngradeHold (C-) ➝ Sell (D+)
10/8/2026
Pfizer Inc. stock logo
PFE
Pfizer
Boost Price TargetNeutral$27.00 ➝ $28.00
10/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
Boost Price TargetOutperform$30.00 ➝ $33.00
10/2/2026
WW International, Inc. stock logo
WW
WW International
Initiated CoverageOutperform$25.00
9/29/2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Reiterated RatingMarket Perform
9/29/2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Reiterated RatingSell
9/22/2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
DowngradeHold ➝ Sell$38.00
(Data available from 10/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$2.35B2.94$0.89 per share33.12$2.38 per share12.41
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$46.80B3.74$4.82 per share8.13$6.58 per share5.96
Pfizer Inc. stock logo
PFE
Pfizer
$62.58B2.68$4.44 per share6.64$15.26 per share1.93
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$2.53B0.43$1.84 per share3.23$7.81 per share0.76
WW International, Inc. stock logo
WW
WW International
$710.64M0.21$12.40 per share1.18($9.62) per share-1.52
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$128.37M-$0.63N/A67.12N/A-5.51%-6.51%-1.20%11/9/2026 (Estimated)
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$15.51B$4.099.4811.471.2935.36%58.61%20.91%11/4/2026 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$7.77B$0.769.589.991.986.80%19.63%8.46%11/3/2026 (Estimated)
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$200.32M-$0.99N/AN/AN/A-7.13%-12.15%-5.83%10/28/2026 (Estimated)
WW International, Inc. stock logo
WW
WW International
-$112.25M-$10.13N/AN/AN/A-56.84%N/A-0.32%11/5/2026 (Estimated)

Latest NVO, PFE, TDOC, HIMS, and WW Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/9/2026Q3 2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$0.0566N/AN/AN/A$892.88 millionN/A
11/5/2026Q3 2026
WW International, Inc. stock logo
WW
WW International
$0.6330N/AN/AN/A$152.33 millionN/A
11/4/2026Q3 2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.74N/AN/AN/A$11.09 billionN/A
11/3/2026Q3 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.7330N/AN/AN/A$15.91 billionN/A
10/28/2026Q3 2026
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$0.2171N/AN/AN/A$588.45 millionN/A
8/10/2026Q2 2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-$0.0498-$0.37-$0.3202-$0.37$698.90 million$753.21 million
8/5/2026Q2 2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.77$0.96+$0.19$0.72$10.89 billion$11.98 billion
8/5/2026Q2 2026
WW International, Inc. stock logo
WW
WW International
$0.48$1.41+$0.93$1.41$159.13 million$162.32 million
8/4/2026Q2 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.6820$0.77+$0.0880-$0.04$14.40 billion$15.03 billion
7/29/2026Q2 2026
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$0.2498-$0.21+$0.0398-$0.21$615.44 million$606.93 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/AN/AN/AN/AN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.822.09%+21.74%20.05%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.725.84%-13.20%226.32%16 Years
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
N/AN/AN/AN/AN/A
WW International, Inc. stock logo
WW
WW International
N/AN/AN/AN/AN/A

Latest NVO, PFE, TDOC, HIMS, and WW Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.436.26%11/6/202611/6/202612/7/2026
8/5/2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.57862.58%8/17/20268/17/20268/25/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
4.21
0.93
0.87
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.55
0.87
0.66
Pfizer Inc. stock logo
PFE
Pfizer
0.71
1.27
0.96
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
N/A
0.83
0.81
WW International, Inc. stock logo
WW
WW International
N/A
0.53
0.53

Institutional Ownership

CompanyInstitutional Ownership
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
63.52%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
11.54%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
76.82%
WW International, Inc. stock logo
WW
WW International
86.18%

Insider Ownership

CompanyInsider Ownership
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
11.76%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.07%
Pfizer Inc. stock logo
PFE
Pfizer
0.62%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
0.70%
WW International, Inc. stock logo
WW
WW International
0.39%
CompanyEmployeesShares OutstandingFree FloatOptionable
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2,442233.31 million205.88 millionOptionable
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
69,5054.47 billion4.46 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
75,0005.70 billion5.66 billionOptionable
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
5,600181.68 million180.41 millionOptionable
WW International, Inc. stock logo
WW
WW International
3,50010.00 million73.38 millionOptionable

Recent News About These Companies

Critical Survey: Youdao (NYSE:DAO) & WW International (NASDAQ:WW)
Q3 Earnings Forecast for WW Issued By Northland Securities
Why WeightWatchers (WW) Stock Is Falling Today
Google, Weight Watchers Collaborate on Health Technology
WeightWatchers (WW) Stock Trades Up, Here Is Why
WW International Appoints Stephen Bye as CEO

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Hims & Hers Health stock logo

Hims & Hers Health NYSE:HIMS

$29.53 +1.81 (+6.54%)
Closing price 10/15/2026 03:59 PM Eastern
Extended Trading
$29.00 -0.53 (-1.79%)
As of 05:23 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Novo Nordisk A/S stock logo

Novo Nordisk A/S NYSE:NVO

$39.22 +1.10 (+2.90%)
Closing price 10/15/2026 03:59 PM Eastern
Extended Trading
$39.40 +0.18 (+0.46%)
As of 05:25 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Pfizer stock logo

Pfizer NYSE:PFE

$29.46 +0.26 (+0.87%)
Closing price 10/15/2026 03:59 PM Eastern
Extended Trading
$29.42 -0.04 (-0.15%)
As of 05:24 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Teladoc Health stock logo

Teladoc Health NYSE:TDOC

$5.94 +0.13 (+2.31%)
Closing price 10/15/2026 03:59 PM Eastern
Extended Trading
$5.96 +0.02 (+0.35%)
As of 04:46 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

WW International stock logo

WW International NASDAQ:WW

$14.63 +0.36 (+2.52%)
Closing price 10/15/2026 04:00 PM Eastern
Extended Trading
$14.62 -0.02 (-0.10%)
As of 10/15/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

WW International, Inc. provides weight management products and services worldwide. It offers a range of nutritional, activity, behavioral, and lifestyle tools and approaches products and services. The company also provides various digital subscription products to wellness and weight management business, which provide interactive and personalized resources that allow users to follow its weight management program through its app and web-based platform; and allows members to inspire and support each other by sharing their experiences with other people on weight health journeys. In addition, it licenses its trademarks and other intellectual property in food, beverages, and other relevant consumer products and services, as well as provides publishing services. The company was formerly known as Weight Watchers International, Inc. and changed its name to WW International, Inc. in September 2019. WW International, Inc. was founded in 1961 and is headquartered in New York, New York.